Convalescent Plasma Therapy for Corona Virus Disease 2019: a Long Way to Go but Worth Trying
Open Access
- 1 January 2020
- journal article
- editorial
- Published by Korean Academy of Medical Sciences in Journal of Korean Medical Science
- Vol. 35 (14), e150
- https://doi.org/10.3346/jkms.2020.35.e150
Abstract
Yoo JH. J Korean Med Sci. 2020 Feb;35(14):e150. https://doi.org/10.3346/jkms.2020.35.e150Keywords
This publication has 21 references indexed in Scilit:
- Convalescent plasma: new evidence for an old therapeutic tool?2015
- Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteinsBiochemical and Biophysical Research Communications, 2014
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysisThe Journal of Infectious Diseases, 2014
- Adverse effects of plasma transfusionTransfusion, 2012
- Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR PathwayJournal of Virology, 2011
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus InfectionClinical Infectious Diseases, 2011
- Treatment with Convalescent Plasma for Influenza A (H5N1) InfectionThe New England Journal of Medicine, 2007
- Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospitalJournal of Antimicrobial Chemotherapy, 2005
- Chloroquine is a potent inhibitor of SARS coronavirus infection and spreadVirology Journal, 2005
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004